tiprankstipranks
NeoGenomics (NEO)
NASDAQ:NEO
US Market

NeoGenomics (NEO) Income Statement

Compare
1,823 Followers

NeoGenomics Income Statement

Last quarter (Q3 2024), NeoGenomics's total revenue was $167.82M, an increase of 10.44% from the same quarter last year. In Q3, NeoGenomics's net income was $-17.70M. See NeoGenomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 660.57M$ 591.64M$ 509.73M$ 484.33M$ 444.45M
Gross Profit
$ 290.10M$ 244.60M$ 187.90M$ 187.06M$ 185.89M
Operating Expenses
$ 375.55M$ 352.34M$ 341.00M$ 305.81M$ 199.88M
Depreciation and Amortization
$ 0.00$ 72.58M$ 79.20M$ 62.07M$ 41.89M
EBITDA
$ -92.11M$ -17.61M$ -78.63M$ 52.08M$ 34.85M
Operating Income
$ -92.11M$ -107.74M$ -153.11M$ -9.99M$ -2.13M
Other Income/Expenses
$ 13.38M$ 10.64M$ -1.72M$ 103.68M$ -64.00K
Pretax Income
$ -78.73M$ -97.10M$ -159.34M$ -15.07M$ -14.06M
Net Income
$ -78.73M$ -87.97M$ -144.25M$ -8.35M$ 4.17M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.62$ -0.70$ -1.16$ -0.07$ 0.04
Diluted EPS
$ -0.62$ -0.70$ -1.16$ -0.07$ 0.04
Weighted Average Shares Outstanding
126.66M 125.50M 124.22M 119.96M 108.58M
Weighted Average Shares Outstanding (Diluted)
126.66M 125.50M 124.22M 119.96M 111.79M
Currency in USD

NeoGenomics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis